FIGS, Inc. FIGS
Our mission is to celebrate, empower and serve those who serve others.
We are a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. We are committed to helping this growing, global community of professionals, whom we refer to as Awesome Humans, look, feel and perform at their best—24/7, 365 days a year. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function and style, all at an affordable price. In doing so, we have redefined what scrubs are—giving rise to our tag-line: why wear scrubs, when you can #wearFIGS?
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $631.1M | $555.6M | $545.6M | $505.8M | $419.6M | $263.1M | $110.5M | — |
| Cost of revenue | $211.3M | $179.9M | $168.7M | $151.4M | $118.4M | $72.9M | $31.2M | — |
| Gross profit | $419.8M | $375.6M | $377.0M | $354.5M | $301.2M | $190.2M | $79.3M | — |
| SG&A | $142.7M | $142.9M | $140.7M | $120.7M | $149.6M | $41.5M | $21.6M | — |
| Total operating expenses | $381.7M | $373.4M | $342.9M | $316.8M | $290.2M | $132.3M | $79.7M | — |
| Operating income | $38.1M | $2.3M | $34.0M | $37.7M | $11.0M | $57.9M | -$347.0K | — |
| Interest expense | — | — | $6.8M | $1.7M | $239.0K | $136.0K | $460.0K | — |
| Pre-tax income | $47.2M | $14.3M | $40.8M | $38.7M | $9.9M | $58.1M | $112.0K | — |
| Income tax | $13.0M | $11.6M | $18.2M | $17.5M | $19.4M | $8.3M | $0 | — |
| Net income | $34.3M | $2.7M | $22.6M | $21.2M | -$9.6M | $49.8M | $112.0K | — |
| EPS, basic | 0.21 | 0.02 | 0.13 | 0.13 | -0.06 | 0.32 | 0.00 | — |
| EPS, diluted | 0.19 | 0.02 | 0.12 | 0.11 | -0.06 | 0.30 | 0.00 | — |
| Shares, diluted (wtd. avg.) | $179.5M | $180.1M | $182.4M | $187.5M | $159.2M | $163.3M | $153.6M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $82.0M | $85.6M | $144.2M | $159.8M | $197.4M | $58.1M | $38.4M | $22.6M |
| Short-term investments | $218.9M | $159.5M | $102.5M | $0 | — | — | — | — |
| Receivables | $5.4M | $6.6M | $6.5M | $6.3M | $1.7M | $5.8M | — | — |
| Inventory | $128.0M | $115.8M | $119.0M | $178.0M | $86.1M | $49.7M | — | — |
| Total current assets | $447.3M | $382.8M | $385.7M | $356.5M | $293.3M | $120.3M | — | — |
| Property, plant and equipment | $33.9M | $35.3M | $24.9M | $11.0M | $7.6M | $6.5M | — | — |
| Total assets | $580.0M | $509.8M | $473.2M | $395.1M | $311.8M | $133.9M | — | — |
| Accounts payable | $18.2M | $9.4M | $14.7M | $20.9M | $14.6M | $12.0M | — | — |
| Total current liabilities | $90.5M | $90.1M | $57.3M | $71.4M | $62.4M | $32.5M | — | — |
| Total liabilities | $142.5M | $132.7M | $96.4M | $87.3M | $66.2M | $36.2M | — | — |
| Retained earnings | $98.7M | $64.5M | $61.8M | $39.1M | $17.9M | $27.5M | — | — |
| Total equity | $437.5M | $377.1M | $376.9M | $307.7M | $245.6M | $97.7M | $38.8M | $24.5M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $61.2M | $81.2M | $100.9M | -$35.3M | $66.4M | $21.7M | $6.5M | — |
| Depreciation and amortisation | $9.0M | $6.7M | $2.9M | $1.9M | $1.4M | $946.0K | $500.0K | — |
| Stock-based compensation | $26.9M | $42.7M | $45.8M | $37.5M | $81.1M | $8.7M | $179.0K | — |
| Capital expenditure | $8.2M | $17.0M | $16.3M | $5.3M | $2.7M | $2.3M | $4.8M | — |
| Investing cash flow | -$64.0M | -$94.9M | -$117.2M | -$5.8M | -$2.7M | -$2.3M | -$4.8M | — |
| Financing cash flow | -$969.0K | -$44.8M | $670.0K | $3.5M | $75.6M | $294.0K | $14.0M | — |
| Buybacks | $2.7M | $45.5M | $0 | $0 | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-26-026838.
Others in SIC 2300
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LULU | lululemon athletica inc. | $10.62B | 7.6x | 4.9% |
| LEVI | LEVI STRAUSS & CO | $8.35B | 14.5x | 4.1% |
| COLM | COLUMBIA SPORTSWEAR CO | $2.95B | 17.8x | 0.9% |
| UAA | Under Armour, Inc. | $2.25B | — | -3.8% |
| CRI | CARTERS INC | $1.23B | 13.3x | 1.9% |
| GIII | G III APPAREL GROUP LTD /DE/ | $1.17B | 18.4x | -7.0% |
| SGC | SUPERIOR GROUP OF COMPANIES, INC. | $203.0M | 27.7x | 0.1% |
| JRSH | Jerash Holdings (US), Inc. | $70.2M | 20.5x | 14.0% |